# EDGAR Filing Document

**Accession Number:** 0001425627
**File Stem:** 0001477932-25-008109
**Filing Date:** 2025-11
**Character Count:** 24374
**Document Hash:** 667e3391ed588366c7bd3353a2851979
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-008109.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001477932-25-008109

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 20

**CONFORMED PERIOD OF REPORT**: 20251112

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SOBR Safe, Inc.
- **CENTRAL INDEX KEY:** 0001425627
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERIODICALS:  PUBLISHING OR PUBLISHING AND PRINTING [2721]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 260731818
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41396
- **FILM NUMBER:** 251474067

**BUSINESS ADDRESS:**
- **STREET 1:** 6400 S. FIDDLERS GREEN CIRCLE
- **STREET 2:** SUITE 1400
- **CITY:** GREENWOOD VILLAGE
- **STATE:** CO
- **ZIP:** 80111
- **BUSINESS PHONE:** 844-762-7723

**MAIL ADDRESS:**
- **STREET 1:** 6400 S. FIDDLERS GREEN CIRCLE
- **STREET 2:** SUITE 1400
- **CITY:** GREENWOOD VILLAGE
- **STATE:** CO
- **ZIP:** 80111

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TransBiotec, Inc.
- **DATE OF NAME CHANGE:** 20120302

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IMAGINE MEDIA LTD
- **DATE OF NAME CHANGE:** 20080130

?xml version='1.0' encoding='ASCII'? sobr_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **November 12, 2025**

---

| |
|:---|
| **SOBR SAFE, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Delaware** | **000-53316** | **26-0731818** |
| (State or other<br>jurisdiction of incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**6400 S. Fiddlers Green Circle, Suite 1400**

**<u>Greenwood Village, Colorado 80111</u>**

(Address of principal executive offices) (zip code)

**<u>(844) 762-7723</u>**

(Registrant's telephone number, including area code)

(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock | SOBR | The Nasdaq Stock Market LLC <br>(Nasdaq Capital Market) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01. Regulation FD Disclosure.**

On November 12, 2025, the Company sent out a press release announcing its financial and operating results for the third quarter of 2025. The full text of the press release referenced herein is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 7.01 of the Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| [99.1](sobr_ex991.htm) | [Press release dated November 12, 2025](sobr_ex991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SOBR Safe, Inc.**<br>a Delaware corporation | **SOBR Safe, Inc.**<br>a Delaware corporation |
| Dated: November 12, 2025 | By: | */s/ David Gandini* |
|  |  | David Gandini, Chief Executive Officer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

![](sobr_ex991img5.jpg)

**SOBRsafe Reports Third Quarter 2025 Results**

**DENVER, November 12, 2025** – SOBR Safe, Inc. (Nasdaq: SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, is reporting financial and operating results for the third quarter ended September 30, 2025.

**Third Quarter 2025 Operational and Financial Highlights**

· Revenue increased 136.1 % year-over-year.

· Sold 277 SOBRsure<sup>TM</sup> GEN 2 devices, up 55.6% from the second quarter of 2025.

· SOBRsure<sup>TM</sup> GEN 2 related hardware and software revenues contributed 80.7% of total revenue during the quarter and 78.0% year to date.

· Annual recurring revenue from software subscription sales at quarter-end is $152.2 thousand increasing by $57.4 thousand during the quarter, or 60.5%.

· Launched additional targeted marketing campaigns for key national initiatives such as Recovery Month in September as well as two new segment specific campaigns to expand brand awareness outside addiction recovery use cases.

· Refined the Company's marketing strategy to emphasize high-performing regions and new direct-to-consumer audiences, resulting in shorter sales cycles, higher conversion rates, and a 266% quarter-over-quarter increase in website traffic.

· Achieved the highest monthly sales in Company history in October, supported by the addition of two new channel partners, and subsequently received the largest SOBRsure™ GEN 2 device order to date in November.

"The third quarter marked another period of consistent operational progress and growing commercial traction," said SOBRsafe CEO David Gandini. "Since the launch of our SOBRsure™ GEN 2 device and reinvigorated brand platform late last year, we have seen steady month-over-month sales growth, with October representing our strongest sales month to date. Online sales remain a key contributor, supported by our newly enhanced e-commerce platform and more effective digital engagement strategy. We recently secured two new channel partners and continue to see expanding interest from organizations seeking discreet, reliable alcohol monitoring and detection solutions. Across both behavioral health and consumer markets, we are seeing increasing validation that our technology solutions and brand are resonating.

"Our marketing investments are driving measurable results, with website traffic up 266% and conversion rates improving as we refine our campaigns and segmentation. We have a clear end-of-year marketing plan that includes targeted messaging, influencer partnerships, and expanded social media activity designed to strengthen awareness heading into the critical holiday and "dry" January periods. The feedback from both consumers and behavioral health customers reinforces that our brand is gaining recognition and trust, and that our focused strategy is translating into sustained sales momentum.

"While still in the early stages of commercialization, we are executing with focus and alignment around our long-term strategic objectives. SOBRsafe is building meaningful brand awareness and industry credibility, validated by early interest from oversight organizations, healthcare networks, and behavioral health providers. Our priorities are concentrated around accelerating revenue growth across the behavioral health and consumer markets, cultivating global pilot programs that can evolve into licensing partnerships, and expanding our sales organization to support these initiatives. At the same time, we are strengthening our in-house technology expertise, enhancing our software capabilities through advanced analytics and machine learning, and reimagining our SOBRcheck™ and SOBRsure™ products for broader adoption in early 2027. With these initiatives underway, we believe SOBRsafe is well positioned to convert our growing brand recognition and technology leadership into sustainable, scalable growth."

![](sobr_ex991img4.jpg)

**Third Quarter 2025 Financial Results**

Revenue in the third quarter of 2025 increased 136.1% to $108.9 thousand compared to $46.1 thousand for the same period in 2024 and increased 4.5% compared to the second quarter of 2025. The year-over-year and sequential growth was primarily attributable to increased sales for the Company's SOBRsure<sup>TM</sup> device and SOBRsure<sup>TM</sup> software subscriptions.

Gross profit in the third quarter of 2025 increased to $37.9 thousand compared to $30.1 thousand for the same period in 2024. Gross margin was 34.8% in the third quarter of 2025, compared to 65.3% in the third quarter of 2024. The year-over-year decline in margin was largely due to strategic price reductions to the Company's SOBRsure<sup>TM</sup> device and software subscriptions to expand its customer base as well as higher costs associated with product replacements to enhance device quality.

Operating expenses in the third quarter of 2025 were $2.3 million compared to $1.9 million for the prior year period. The increase was reflective of additional general and administrative costs associated with the Company's expanded head count, businesses development costs, and increased marketing efforts.

Net loss in the third quarter of 2025 was $(2.2) million, or $(1.44) per diluted share, compared to a net loss of $(1.8) million, or $(58.26) per diluted share, for the prior year period. Note, the earnings per diluted share in the prior year period has been adjusted for the 1-for-110 and 1-for-10 reverse splits of the Company's common stock on the Nasdaq Capital Markets effected October 2, 2024 and April 4, 2025, respectively. The increase in net loss was primarily attributable to higher operating costs, partially offset by reduced stock-based compensation, and research and development expenses.

Cash and cash equivalents were $4.7 million at September 30, 2025, compared to $8.4 million at December 31, 2024.

**About SOBRsafe™**

Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit <u>www.sobrsafe.com</u>.

**Safe Harbor Statement**

Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at <u>www.sec.gov</u>.

**Company Contact:**

<u>IR@sobrsafe.com</u>

**Investor Relations Contact:**

Scott Liolios or Taylor Stadeli

Gateway Group

949-574-3860

<u>SOBR@gateway-grp.com</u>

![](sobr_ex991img3.jpg)

---

| | | |
|:---|:---|:---|
| **SOBR SAFE, INC.**  | **SOBR SAFE, INC.**  | **SOBR SAFE, INC.**  |
| **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** |
|  | **September 30,** | **December 31,** |
|  | **2025** | **2024** |
| **ASSETS** | (Unaudited) |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Current assets** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash | $4711664 | $8384042 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net | 32384 | 24460 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory | 142230 | 224875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses | 313521 | 192637 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current assets | 19161 | 46060 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total current assets** | 5218960 | 8872074 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Property and equipment, net | 36264 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intellectual technology, net | 1798867 | 2087965 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease right-of-use assets, net | 108769 | 183737 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets | 27427 | 27427 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Assets** | $7190287 | $11171203 |
| **LIABILITIES & STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Current liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable | $394978 | $422557 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | 360012 | 498128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued interest payable | 113422 | 105501 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred revenue | 10092 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities, current portion | 121584 | 111303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Notes payable - related parties, net | 11810 | 11810 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Notes payable - non-related parties, net | 210664 | 127590 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total current liabilities** | 1222562 | 1276889 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities, less current portion | - | 91993 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Liabilities** | 1222562 | 1368882 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Commitments and contingencies** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; **Stockholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock, $0.00001 par value; 100,000,000 shares authorized, 1,516,238 and 936,926 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 15 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury stock, at cost; 17 and 16 shares as of September 30, 2025 and December 31, 2024, respectively | (38015) | (38015) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional paid-in capital | 110499728 | 108222324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulated deficit | (104440303) | (98328395) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total SOBR Safe, Inc. stockholders' equity | 6021425 | 9856008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noncontrolling interest | (53700) | (53687) |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Stockholders' Equity** | 5967725 | 9802321 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total Liabilities and Stockholders' Equity** | $7190287 | $11171203 |

---

![](sobr_ex991img2.jpg)

**SOBR SAFE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For The Three Months Ended**<br> **September 30,** | **For The Three Months Ended**<br> **September 30,** | **For The Nine Months Ended**<br> **September 30,** | **For The Nine Months Ended**<br> **September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| Revenues | $108893 | $46129 | $299738 | $148310 |
| Cost of goods and services | 71026 | 15992 | 151023 | 81929 |
| Gross profit | 37867 | 30137 | 148715 | 66381 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; General and administrative | 2117641 | 1499296 | 5756138 | 4310791 |
| &nbsp;&nbsp;&nbsp;&nbsp; Stock-based compensation expense | 115250 | 184243 | 370180 | 584551 |
| &nbsp;&nbsp;&nbsp;&nbsp; Research and development | 30102 | 194466 | 269701 | 604927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total operating expenses | 2262993 | 1878005 | 6396019 | 5500269 |
| Loss from operations | (2225126) | (1847868) | (6247304) | (5433888) |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Other income, net | 47459 | 12566 | 200889 | 46978 |
| &nbsp;&nbsp;&nbsp;&nbsp; Notes payable – conversion expense |  |  |  | (585875) |
| &nbsp;&nbsp;&nbsp;&nbsp; Interest expense | (8961) | (5908) | (14753) | (451720) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other income (expense), net | 38498 | 6658 | 186136 | (990617) |
| Loss before provision for income taxes | (2186628) | (1841210) | (6061168) | (6424505) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Provision for income taxes | - | - | - | - |
| **Net loss** | (2186628) | (1841210) | (6061168) | (6424505) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net loss attributable to noncontrolling interest | 4 | 4 | 13 | 13 |
| **Net loss attributable to SOBR Safe, Inc.** | $(2186624) | $(1841206) | $(6061155) | $(6424492) |
| &nbsp;&nbsp;&nbsp;&nbsp; Deemed dividends related to Convertible Debt Warrants down round provision |  |  | (1833) | (23270) |
| &nbsp;&nbsp;&nbsp;&nbsp; Deemed dividends related to 2022 PIPE Warrants down round provision |  |  | (1547) | (46875) |
| &nbsp;&nbsp;&nbsp;&nbsp; Deemed dividends related to Original Warrants and New Warrants down round provision |  |  |  | (1455805) |
| &nbsp;&nbsp;&nbsp;&nbsp; Deemed dividends related to 2024 PIPE Warrants round down provision |  |  | (47373) |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Warrant Inducement transactional costs | - | - | - | (341297) |
| &nbsp;&nbsp;&nbsp;&nbsp; **Net loss attributable to common stockholders** | $(2186624) | $(1841206) | $(6111908) | $(8291739) |
| Basic and diluted loss per common share | $(1.44) | $(58.26) | $(4.21) | $(353.65) |
| Weighted average number of common shares outstanding | 1516238 | 31605 | 1451713 | 23446 |

---

![](sobr_ex991img1.jpg)

---

| | | |
|:---|:---|:---|
| **SOBR SAFE, INC.** | **SOBR SAFE, INC.** | **SOBR SAFE, INC.** |
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** |
|  | **For The Nine Months Ended** | **For The Nine Months Ended** |
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
|  | (Unaudited) | (Unaudited) |
| **Operating Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Net loss | $(6061168) | $(6424505) |
| &nbsp;&nbsp;&nbsp;&nbsp; Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization and depreciation | 291006 | 289098 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of debt discounts |  | 237250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash lease expense | 74968 | 67315 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash interest expense | 7921 | 336510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash conversion expense |  | 585875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bad debt expense | 9490 | 202 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-based compensation expense | 370182 | 584551 |
| &nbsp;&nbsp;&nbsp;&nbsp; Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable | (17414) | (20573) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory | 82645 | 72798 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses | 152161 | 86566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets | 26899 | (21534) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts payable | (27579) | (200355) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | (168017) | (306941) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued interest payable |  | (126086) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred revenue | 10092 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities | (81712) | (71199) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net cash used in operating activities** | (5330526) | (4911028) |
| **Investing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase of property and equipment | (38172) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net cash used in investing activities** | (38172) |  |
| **Financing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repayments of notes payable - non-related parties | (160070) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from exercise of stock warrants | 3680411 | 2786174 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of transactional costs for exercise of warrants | (184021) | (360756) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of 2024 PIPE Warrant True-up Payment | (1640000) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Net cash provided by financing activities** | 1696320 | 2425418 |
| **Net Change In Cash** | (3672378) | (2485610) |
| **Cash At The Beginning Of The Period** | 8384042 | 2790147 |
| **Cash At The End Of The Period** | $4711664 | $304537 |
| **Schedule Of Non-Cash Investing And Financing Activities:** |  |  |
| Deemed dividends related to Convertible Debt Warrants down round provision | $(1833) | $23270 |
| Deemed dividends related to 2022 PIPE Warrants down round provision | $(1547) | $46875 |
| Deemed dividends related to Original Warrants and New Warrants down round provision | $- | $1455805 |
| Deemed dividends related to 2024 PIPE warrants round down provision | $(47373) | $- |
| Non-related party debt converted to capital | $- | $2879279 |
| Warrant inducement transactional costs | $- | $341297 |
| Financing of prepaid insurance premiums | $- | $(161896) |
| **Supplemental Disclosure:** |  |  |
| Cash paid for interest | $6833 | $266 |
| Cash paid for income taxes | $- | $- |

---